Ribavirin

CD4 molecule ; Homo sapiens







20 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 28040549 Increased peripheral CD4+ regulatory T cells persist after successful direct-acting antiviral treatment of chronic hepatitis C. 2017 May 1
2 25688301 Long-Term Consequences of Hepatitis C Viral Clearance on the CD4 (+) T Cell Lymphocyte Course in HIV/HCV Coinfected Patients. 2015 1
3 25823618 Hepatitis C therapy with interferon-α and ribavirin reduces the CD4 cell count and the total, 2LTR circular and integrated HIV-1 DNA in HIV/HCV co-infected patients. 2015 Jun 1
4 26019032 Association of baseline CD4+ cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients. 2015 Jul-Aug 1
5 24021786 [Effect of antiviral treatment on expression of programmed death 1 and programmed death ligand 1 on peripheral T lymphocytes in patients with chronic hepatitis C]. 2013 Apr 1
6 21871023 Ribavirin downmodulates inducible costimulator on CD4+ T cells and their interleukin-10 secretion to assist in hepatitis C virus clearance. 2012 Apr 4
7 21934116 AIDS-related Kaposi's sarcoma can occur during peginterferon-α and ribavirin therapy for chronic hepatitis C infection. 2012 Jan-Feb 2
8 22220723 Short communication: impact of hepatitis C viral clearance on CD4+ T-lymphocyte course in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin. 2012 Sep 2
9 22588246 Sequential immunological analysis of HBV/HCV co-infected patients during Peg-IFN/RBV therapy. 2012 Dec 1
10 22848715 Ribavirin exerts differential effects on functions of Cd4+ Th1, Th2, and regulatory T cell clones in hepatitis C. 2012 2
11 22891772 Ribavirin modulates the conversion of human CD4(+)  CD25(-) T cell to CD4(+)  CD25(+)  FOXP3(+) T cell via suppressing interleukin-10-producing regulatory T cell. 2012 Nov 9
12 20487258 A prospective study of T- and B-lymphocyte subpopulations, CD81 expression levels on B cells and regulatory CD4(+) CD25(+) CD127(low/-) FoxP3(+) T cells in patients with chronic HCV infection during pegylated interferon-alpha2a plus ribavirin treatment. 2011 Jun 1
13 21606538 Concomitant highly active antiretroviral therapy leads to smaller decline and faster recovery of CD4+ cell counts during and after pegylated interferon plus ribavirin therapy in HIV-hepatitis C virus coinfected patients. 2011 Jun 15 1
14 19423402 CXCR3 expression on peripheral CD4+ T cells as a predictive marker of response to treatment in chronic hepatitis C. 2009 Jul 1
15 18156991 Baseline CD4 cell count and outcome of pegylated interferon plus ribavirin therapy in HIV/hepatitis C virus-coinfected patients. 2008 Jan 1 1
16 18514579 Immune responses during acute and chronic infection with hepatitis C virus. 2008 Aug 1
17 17397001 CD4+ T cell responses in patients with chronic hepatitis C undergoing peginterferon/ribavirin therapy correlate with faster, but not sustained, viral clearance. 2007 May 1 1
18 16400748 Treatment of hepatitis C in HIV-infected patients: regularly reassess the benefits and risks. 2005 Dec 1
19 12390318 Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo. 2002 Nov 3
20 11112228 Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues. 2000 Dec 11-25 1